Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α

Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α

Li-rui Tang,1,* Jun-xin Wu,1,* Shao-li Cai,2 Yun-xia Huang,1 Xue-qing Zhang,1 Wan-kai Fu,1 Qing-yang Zhuang,1 Jin-luan Li1 1Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China; 2Key Laboratories of Innate Immune Biology of Fujian Provin...

Full description

Bibliographic Details
Main Authors:	Tang L, Wu J, Cai S, Huang Y, Zhang X, Fu W, Zhuang Q, Li J
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-11-01
Series:	OncoTargets and Therapy
Subjects:	pancreatic cancer PHD3 radiotherapy efficacy HIF-1α p-EGFR
Online Access:	https://www.dovepress.com/prolyl-hydroxylase-domain-3-influences-the-radiotherapy-efficacy-of-pa-peer-reviewed-article-OTT

Similar Items

HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer—Potential Targets for Anti-Tumor Therapy?
by: Diana Gaete, et al.
Published: (2021-02-01)

Hyperplasia and hypertrophy of pulmonary neuroepithelial bodies, presumed airway hypoxia sensors, in hypoxia-inducible factor prolyl hydroxylase-deficient mice
by: Pan J, et al.
Published: (2016-04-01)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
by: Maria Savyuk, et al.
Published: (2020-07-01)

Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
by: So Yeon Kim, et al.
Published: (2015-11-01)

Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner
by: Lexiao Li, et al.
Published: (2016-07-01)

Hypoxia-Inducible Factor 2-Alpha Mediated Gene Sets Differentiate Pulmonary Arterial Hypertension
by: Jinsheng Zhu, et al.
Published: (2021-08-01)

Effect of conjugated linoleic acid on inhibition of prolyl hydroxylase 1 in hearts of mice
by: Zhang Jize, et al.
Published: (2012-02-01)

A novel role for prolyl-hydroxylase 3 gene silencing in epithelial-to-mesenchymal-like transition
by: Place, Trenton Lane
Published: (2013)

STIM1 overexpression in hypoxia microenvironment contributes to pancreatic carcinoma progression
by: Jian Wang, et al.
Published: (2019-03-01)

Einfluss des Prolyl-4-Hydroxylase-Domäne 2-Enzyms auf die Migration der myeloischen Zelllinien RAW und J774
by: Steinhardt, Maximilian Johannes
Published: (2017)

Selective Inhibition and Mechanistic Studies of the Human O2 Sensor, Prolyl Hydroxylase Domain 2 (PHD2)
by: Flagg, Shannon Coates
Published: (2011)

Cardiomyocyte-Specific Transgenic Expression of Prolyl-4-Hydroxylase Domain 3 Impairs the Myocardial Response to Ischemia
by: Anke Zieseniss, et al.
Published: (2015-05-01)

Bacterial Lysate from the Multi-Strain Probiotic SLAB51 Triggers Adaptative Responses to Hypoxia in Human Caco-2 Intestinal Epithelial Cells under Normoxic Conditions and Attenuates LPS-Induced Inflammatory Response
by: Altamura, S., et al.
Published: (2023)

Born to sense: biophysical analyses of the oxygen sensing prolyl hydroxylase from the simplest animal Trichoplax adhaerens
by: Lippl K, et al.
Published: (2018-11-01)

Regnase-1 Maintains Iron Homeostasis via the Degradation of Transferrin Receptor 1 and Prolyl-Hydroxylase-Domain-Containing Protein 3 mRNAs
by: Masanori Yoshinaga, et al.
Published: (2017-05-01)

Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function
by: Xuan Li, et al.
Published: (2018-04-01)

Hypoxia in Solid Tumors: How Low Oxygenation Impacts the “Six Rs” of Radiotherapy
by: Andria Rakotomalala, et al.
Published: (2021-09-01)

Hypoxia-inducible factor prolyl 4-hydroxylase-2 in cardiac and skeletal muscle ischemia and metabolism
by: Karsikas, S. (Sara)
Published: (2015)

The total flavonoid of Eucommia ulmoides sensitizes human glioblastoma cells to radiotherapy via HIF-α/MMP-2 pathway and activates intrinsic apoptosis pathway
by: Wang Y, et al.
Published: (2019-07-01)

Regnase-1 Maintains Iron Homeostasis via the Degradation of Transferrin Receptor 1 and Prolyl-Hydroxylase-Domain-Containing Protein 3 mRNAs
by: Yoshinaga, Masanori
Published: (2020)

Hypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair
by: Shaoqun Shu, et al.
Published: (2019-02-01)

Relative Contribution of Prolyl Hydroxylase-Dependent and -Independent Degradation of HIF-1alpha by Proteasomal Pathways in Cerebral Ischemia
by: Yomna Badawi, et al.
Published: (2017-05-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
by: Kiichi Hirota
Published: (2021-04-01)

Expression and Roles of Individual HIF Prolyl 4-Hydroxylase Isoenzymes in the Regulation of the Hypoxia Response Pathway along the Murine Gastrointestinal Epithelium
by: Franziska Dengler, et al.
Published: (2021-04-01)

Inhibition of HIF-prolyl 4-hydroxylases as a promising approach to the therapy of cardiometabolic diseases
by: K A Aitbaev, et al.
Published: (2018-08-01)

Stratégie de sensibilisation des tumeurs des voies aérodigestives supérieures aux anti-EGFR et résistance induite : induction de HIF-2 et opportunité thérapeutique
by: Coliat, Pierre
Published: (2015)

VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo
by: Guangbo Kang, et al.
Published: (2021-08-01)

Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer
by: Xiao Jin, et al.
Published: (2020-06-01)

MORG1 +/− mice are protected from histological renal damage and inflammation in a murine model of endotoxemia
by: Tzvetanka Bondeva, et al.
Published: (2018-02-01)

Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
by: Megan L. Noonan, et al.
Published: (2020-06-01)

CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells
by: Koki Maeda, et al.
Published: (2016-06-01)

The Linkage between Breast Cancer, Hypoxia, and Adipose Tissue
by: Linda K. Rausch, et al.
Published: (2017-09-01)

Dysregulated expression of hypoxia-inducible factors augments myofibroblasts differentiation in idiopathic pulmonary fibrosis
by: Arnoldo Aquino-Gálvez, et al.
Published: (2019-06-01)

Modeling dioxygenase enzyme kinetics in familial paraganglioma
by: Justin P. Peters, et al.
Published: (2015-10-01)

Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently
by: Swetlana Rot, et al.
Published: (2018-12-01)

Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions
by: Swain, Lija
Published: (2014)

Hétérogénéité génétique de la polyglobulie
by: Al-Sheikh, Maha
Published: (2008)

The Role of Hypoxia in Glioblastoma Radiotherapy Resistance
by: Agathe L. Chédeville, et al.
Published: (2021-02-01)

Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis
by: Chaobin He, et al.
Published: (2019-04-01)

MicroRNA-224 Promotes Pancreatic Cancer Cell Proliferation and Migration by Targeting the TXNIP-Mediated HIF1α Pathway
by: Guanghui Zhu, et al.
Published: (2018-08-01)